Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Volv Global"'
The ubiquity of smartphones in modern life suggests the possibility to use them to continuously monitor patients, for instance to detect undiagnosed diseases or track treatment progress. Such data collection and analysis may be especially beneficial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d9950212815cca3d32e1a77eae847be
https://doi.org/10.1101/2020.10.03.20206235
https://doi.org/10.1101/2020.10.03.20206235
Autor:
Colbaugh, Rich, Glass, Kristin, Rudolf, Christopher, Tremblay Volv Global, Lausanne, Switzerland, Mike
There is increasing interest in developing prediction models capable of identifying rare disease patients in population-scale databases such as electronic health records (EHRs). Deriving these models is challenging for many reasons, perhaps the most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::14a0e1d5eaddd05547a968536bf37f0c
https://europepmc.org/articles/PMC6371307/
https://europepmc.org/articles/PMC6371307/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Machine-Learning Model Identifies Patients With Alpha-1 Antitrypsin Deficiency Using Claims Records.
Autor:
Sharma R; Center for Liver Disease and Transplantation, Columbia University Irving Medical Center, New York, NY, USA., Hogarth DK; Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, IL, USA., Colbaugh R; Volv Global SA, Epalinges, Switzerland., Glass K; Volv Global SA, Epalinges, Switzerland., Mezine A; Volv Global SA, Epalinges, Switzerland., Liakoni V; Volv Global SA, Epalinges, Switzerland., Rudolf C; Volv Global SA, Epalinges, Switzerland., Himmelhan I; Takeda Pharmaceuticals International AG, Zürich, Switzerland., Hinson J; Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA., Sanchirico M; Takeda Pharmaceuticals USA, Inc., Lexington, MA, USA.
Publikováno v:
COPD [COPD] 2024 Dec; Vol. 21 (1), pp. 2393348. Date of Electronic Publication: 2024 Sep 23.